Human Jejunal Permeability of Two Polar Drugs: Cimetidine and Ranitidine
dc.contributor.author | Lennernäs, Hans | en_US |
dc.contributor.author | Yamamoto, Ryuzo | en_US |
dc.contributor.author | Hussain, Ajaz S. | en_US |
dc.contributor.author | Takamatsu, Narushi | en_US |
dc.contributor.author | Barnett, Jeffrey L. | en_US |
dc.contributor.author | Kim, Ok-Nam | en_US |
dc.contributor.author | Lipka, Elke | en_US |
dc.contributor.author | Hayashi, Yayoi | en_US |
dc.contributor.author | Welage, Lynda S. | en_US |
dc.contributor.author | Lesko, Lawrence J. | en_US |
dc.contributor.author | Amidon, Gordon L. | en_US |
dc.contributor.author | Idkaidek, Nasir M. | en_US |
dc.date.accessioned | 2006-09-08T19:18:32Z | |
dc.date.available | 2006-09-08T19:18:32Z | |
dc.date.issued | 2001-06 | en_US |
dc.identifier.citation | Takamatsu, Narushi; Kim, Ok-Nam; Welage, Lynda S.; Idkaidek, Nasir M.; Hayashi, Yayoi; Barnett, Jeffrey; Yamamoto, Ryuzo; Lipka, Elke; Lennernäs, Hans; Hussain, Ajaz; Lesko, Lawrence; Amidon, Gordon L.; (2001). "Human Jejunal Permeability of Two Polar Drugs: Cimetidine and Ranitidine." Pharmaceutical Research 18(6): 742-744. <http://hdl.handle.net/2027.42/41484> | en_US |
dc.identifier.issn | 1573-904X | en_US |
dc.identifier.issn | 0724-8741 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/41484 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=11474776&dopt=citation | en_US |
dc.description.abstract | Purpose . To determine the human jejunal permeability of cimetidine and ranitidine using a regional jejunal perfusion approach, and to integrate such determinations with previous efforts to establish a baseline correlation between permeability and fraction dose absorbed in humans for soluble drugs. | en_US |
dc.format.extent | 114064 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Kluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Media | en_US |
dc.subject.other | Pharmacology/Toxicology | en_US |
dc.subject.other | Intestinal Permeability | en_US |
dc.subject.other | Biopharmaceutic Classification System | en_US |
dc.subject.other | Cimetidine | en_US |
dc.subject.other | Drug Absorption | en_US |
dc.subject.other | Ranitidine | en_US |
dc.subject.other | Biomedicine | en_US |
dc.subject.other | Pharmacy | en_US |
dc.subject.other | Medical Law | en_US |
dc.subject.other | Biochemistry, General | en_US |
dc.subject.other | Biomedical Engineering | en_US |
dc.title | Human Jejunal Permeability of Two Polar Drugs: Cimetidine and Ranitidine | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Medical School, The University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | College of Pharmacy, The University of Michigan, USA; Pharmacy Services, University Hospital, Ann Arbor, Michigan, 48109 | en_US |
dc.contributor.affiliationother | Office of Research Resources, CDER, FDA, Rockville, Maryland, 20852 | en_US |
dc.contributor.affiliationother | Yamanouchi Pharmaceutical Co. Ltd., Shizuoka, Japan | en_US |
dc.contributor.affiliationother | Sookmyung Women' University, Seoul, 140-742, Korea | en_US |
dc.contributor.affiliationother | Office of Research Resources, CDER, FDA, Rockville, Maryland, 20852 | en_US |
dc.contributor.affiliationother | School of Pharmacy, Uppsala University, Uppsala, Sweden | en_US |
dc.contributor.affiliationother | Office of Clinical Pharmacology and Biopharmaceutics, CDER, FDA, Rockville, Maryland, 20852 | en_US |
dc.contributor.affiliationother | Nagoya City University, Aichi, Japan | en_US |
dc.contributor.affiliationother | Jordan University of Science and Technology, Irbid, Jordan | en_US |
dc.contributor.affiliationother | Ono Pharmaceutical Co. Ltd., c, Osaka, Japan, 618 | en_US |
dc.contributor.affiliationother | Pfizer Global R&D, Ann Arbor, Michigan, 48105 | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 11474776 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/41484/1/11095_2004_Article_302739.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1023/A:1011020025338 | en_US |
dc.identifier.source | Pharmaceutical Research | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.